(1<i>R</i>,2<i>R</i>,6<i>S</i>)-3-Methyl-6-(3-(4-phenylpiperidin-1-yl)prop-1-en-2-yl)cyclohex-3-ene-1,2-diol
Parkinson’s disease (PD) is a progressive neurodegenerative disorder whose primary manifestation is motor dysfunction. Previous research showed that (1<i>R</i>,2<i>R</i>,6<i>S</i>)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol (Prottremine) exhibits potent antiparkinsonian activity in animal mo...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI AG
2025-11-01
|
| Seri Bilgileri: | Molbank |
| Konular: | |
| Online Erişim: | https://www.mdpi.com/1422-8599/2025/4/M2088 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|
